September 22, 2015
Biofrontera: Ameluz and BF-RhodoLED a great team in photodynamic field therapy
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has announced that preliminary long-term results of the Phase III trial for…
You must be logged in to post a comment.